MARLOWE; Charles K.
Patent Applications and Registrations
Patent applications and USPTO patent grants for MARLOWE; Charles K..The latest application filed is for "use of type i and type ii polyketide synthases for the production of cannabinoids and cannabinoid analogs".
Company Profile
2.24.23
- MARLOWE; Charles K. - Emerald Hills CA
- Marlowe; Charles K. - Redwood City CA
- Marlowe, Charles K. - Redwood CA
- Marlowe; Charles K. - Belmont CA
- Marlowe; Charles K. - San Carlos CA
Patent Activity
| Patent | Date |
|---|---|
| Cannabinoid Analogs And Methods For Their Preparation App 20210403408 - BARR; Philip J. ; et al. | 2021-12-30 |
| Use Of Type I And Type Ii Polyketide Synthases For The Production Of Cannabinoids And Cannabinoid Analogs App 20210403959 - BARR; Philip J. ; et al. | 2021-12-30 |
| Recombinant Production Systems For Prenylated Polyketides Of The Cannabinoid Family App 20210040512 - Barr; Philip J. ; et al. | 2021-02-11 |
| Recombinant production systems for prenylated polyketides of the cannabinoid family Grant 10,837,031 - Barr , et al. November 17, 2 | 2020-11-17 |
| Recombinant Production Systems For Prenylated Polyketides Of The Cannabinoid Family App 20180334692 - Barr; Philip J. ; et al. | 2018-11-22 |
| Phosphatidylinositol 3-kinase inhibitors and methods of their use Grant 8,889,664 - Bajjalieh , et al. November 18, 2 | 2014-11-18 |
| Platelet Adp Receptor Inhibitors App 20140221405 - Scarborough; Robert M. ; et al. | 2014-08-07 |
| Inhibitors of the hedgehog pathway Grant 8,796,294 - Bahceci , et al. August 5, 2 | 2014-08-05 |
| Inhibitors of the hedgehog pathway Grant 8,754,092 - Bahceci , et al. June 17, 2 | 2014-06-17 |
| Platelet ADP receptor inhibitors Grant 8,524,721 - Scarborough , et al. September 3, 2 | 2013-09-03 |
| Inhibitors Of The Hedgehog Pathway App 20120245139 - Bahceci; Suleyman ; et al. | 2012-09-27 |
| Inhibitors Of The Hedgehog Pathway App 20120238570 - Bahceci; Suleyman ; et al. | 2012-09-20 |
| Inhibitors of hedgehog pathway Grant 8,222,263 - Bahceci , et al. July 17, 2 | 2012-07-17 |
| Platelet Adp Receptor Inhibitors App 20120149688 - Scarborough; Robert M. ; et al. | 2012-06-14 |
| Platelet ADP receptor inhibitors Grant 8,067,428 - Scarborough , et al. November 29, 2 | 2011-11-29 |
| Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use App 20110207712 - Bajjalieh; William ; et al. | 2011-08-25 |
| Phosphatidylinositol 3-kinase inhibitors and methods of their use Grant 7,989,622 - Bajjalieh , et al. August 2, 2 | 2011-08-02 |
| Platelet Adp Receptor Inhibitors App 20100234350 - Scarborough; Robert M. ; et al. | 2010-09-16 |
| Pyrido [2, 3-d] Pyrimidin-7-one Compounds As Inhibitors Of P13k-alpha For The Treatment Of Cancer App 20100150827 - Buhr; Chris A. ; et al. | 2010-06-17 |
| Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use App 20100087440 - Bajjalieh; William ; et al. | 2010-04-08 |
| Platelet ADP receptor inhibitors Grant 7,622,474 - Scarborough , et al. November 24, 2 | 2009-11-24 |
| Inhibitors Of Hedgehog Pathway App 20090105211 - Bahceci; Suleyman ; et al. | 2009-04-23 |
| Platelet Adp Receptor Inhibitors App 20080194597 - SCARBOROUGH; ROBERT M. ; et al. | 2008-08-14 |
| Platelet ADP receptor inhibitors Grant 7,358,257 - Scarborough , et al. April 15, 2 | 2008-04-15 |
| Substituted isoquinolinones Grant 7,294,635 - Scarborough , et al. November 13, 2 | 2007-11-13 |
| Platelet ADP receptor inhibitors App 20060194795 - Scarborough; Robert M. ; et al. | 2006-08-31 |
| Platelet ADP receptor inhibitors Grant 7,056,926 - Scarborough , et al. June 6, 2 | 2006-06-06 |
| Platelet ADP receptor inhibitors App 20050228029 - Scarborough, Robert M. ; et al. | 2005-10-13 |
| Platelet ADP receptor inhibitors Grant 6,906,063 - Scarborough , et al. June 14, 2 | 2005-06-14 |
| Substituted isoquinolinones App 20050113399 - Scarborough, Robert M. ; et al. | 2005-05-26 |
| Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors App 20040029867 - Scarborough, Robert M. ; et al. | 2004-02-12 |
| Isoquinolone inhibitors of factor Xa App 20030186972 - Marlowe, Charles K. ; et al. | 2003-10-02 |
| Oxindole inhibitors of factor Xa Grant 6,548,517 - Marlowe , et al. April 15, 2 | 2003-04-15 |
| Isoquinolone inhibitors of factor Xa Grant 6,469,026 - Marlowe , et al. October 22, 2 | 2002-10-22 |
| Platelet ADP receptor inhibitors App 20020077486 - Scarborough, Robert M. ; et al. | 2002-06-20 |
| Isoquinolone inhibitors of factor Xa App 20020058677 - Marlowe, Charles K. ; et al. | 2002-05-16 |
| Oxindole inhibitors of factor Xa App 20020052368 - Marlowe, Charles K. ; et al. | 2002-05-02 |
| Bicyclic sulfonyl amino inhibitors of factor Xa App 20020019394 - Li, Wenhao ; et al. | 2002-02-14 |
| Selective factor Xa inhibitors Grant 6,211,183 - Marlowe , et al. April 3, 2 | 2001-04-03 |
| Ketoheterocyclic inhibitors of factor Xa Grant 6,211,154 - Scarborough , et al. April 3, 2 | 2001-04-03 |
| Ketoheterocyclic inhibitors of factor Xa Grant 6,022,861 - Scarborough , et al. February 8, 2 | 2000-02-08 |
| Synthesis of N-substituted oligomers Grant 5,877,278 - Zuckermann , et al. March 2, 1 | 1999-03-02 |
| Inhibitors of factor Xa Grant 5,721,214 - Marlowe , et al. February 24, 1 | 1998-02-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 